Medical Grand Rounds, October 14, 2021

powernephron
Published on Feb 8, 2022
VIDEO EMBED ORIGINAL SOURCE - Department of Medicine McMaster University
https://www.youtube.com/channel/UCvF2UX6pA0Yr8IEgA1O5AKQ/videos
Speaker: Dr. Shervin Zandi, Assistant Clinical Professor, Department of Medicine

Objectives:
• Review the evidence of SGLT2 inhibitors in:
• Diabetes
• Heart Failure
• Chronic Kidney Disease
• Special considerations/precautions of SGLT2 inhibitors